Table 1.
Clinical characteristics.
| n | Mean (±SD) | Median (range) | |
|---|---|---|---|
| Age, y | 30 | 58 (±9.93) | 59 (45–70) |
| Height, m | 30 | 1.70 (±0.11) | 1.70 |
| Weight, kg | 30 | 83 (±18.62) | 81 |
| Waist, cm | 28 | 104 (±38.48) | 98 |
| BMI, (kg/m)2 | 30 | 28 (±4.76) | 28 |
| PreOp hemoglobin, mg/dL | 30 | 13 (±1.16) | 13 |
| PreOp fasting glucose, mg/dL | 30 | 103 (±24.63) | 100 |
| PreOp creatinine, mg/dL | 28 | 1.03 (±0.24) | 1.00 |
| Length of hospital stay, d | 30 | 12 (±13.91) | 7 |
| Length of ICU stay, d | 30 | 4 (±13.39) | 0 |
|
| |||
| n (%) | |||
|
| |||
| Sex, female | 11 (37) | ||
| Obesity, n (%) | 10 (33) | ||
| Abdominal obesity, n (%) | 13 (46) | ||
| Smoker, n (%) | 21 (70) | ||
| Coronary artery disease**, n (%) | 1 (3) | ||
| Hypertension, n (%) | 13 (43) | ||
| Diabetes, n (%) | 4 (13) | ||
| Dyslipidemia, n (%) | 13 (43) | ||
| Statin therapy, n (%) | 5 (17) | ||
| β-Blocker therapy, n (%) | 6 (20) | ||
| ACE-inhibitor therapy, n (%) | 4 (13) | ||
| ASA risk score > 2, n (%) | 28 (93) | ||
| Lee Cardiac Risk Index > 2, n (%) | 3 (10) | ||
| Chemotherapy, n (%) | 13 (43) | ||
| Radiation therapy, n (%) | 10 (33) | ||
**Patient status after myocardial infarction (with or without intervention).